Unexpected Dramatic Evolution of Placenta Increta: Case Report and Literature Review
- PMID: 38003877
- PMCID: PMC10671948
- DOI: 10.3390/jpm13111563
Unexpected Dramatic Evolution of Placenta Increta: Case Report and Literature Review
Abstract
Placental morbid adherence is a known risk factor for postpartum hemorrhage. The incidence of abnormal placental attachment has been increasing over the past few decades, mainly due to rising rates of cesarean deliveries, advanced maternal age, and the use of assisted reproductive technologies. Cesarean section is a significant risk factor for placenta increta, as it disrupts the normal architecture of the uterine wall, making it more difficult for the placenta to detach after delivery. We present the case of a woman who underwent a cesarean section at 28 weeks due to anterior placenta previa, accompanied by hemorrhage and rupture of membranes. Following the delivery, she experienced normal postoperative bleeding and was discharged home after five days. However, six weeks later, she presented with heavy bleeding, leading to the decision to perform a total hysterectomy. The levels of HCG were found to be low. The pathological examination of the specimens confirmed a diagnosis of placenta increta, as it revealed notable placental proliferation, necrotic villi, and placental invasion near the uterine serosa. Notably, we did not find any similar cases documented in the literature. Patients experiencing prolonged vaginal bleeding after childbirth and diagnosed with placenta accreta should be closely monitored through ultrasound examinations; abnormal proliferation of the placenta can occur, and prompt detection is crucial for appropriate management.
Keywords: cesarean section; placenta increta; postpartum hemorrhage.
Conflict of interest statement
The authors declare no conflict of interest.
Figures










Similar articles
-
Placenta previa increta/percreta in Japan: a retrospective study of ultrasound findings, management and clinical course.J Obstet Gynaecol Res. 2007 Oct;33(5):606-11. doi: 10.1111/j.1447-0756.2007.00619.x. J Obstet Gynaecol Res. 2007. PMID: 17845316
-
Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.Ultrasound Obstet Gynecol. 2022 Apr;59(4):474-482. doi: 10.1002/uog.23732. Epub 2022 Mar 8. Ultrasound Obstet Gynecol. 2022. PMID: 34225385 Free PMC article.
-
Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.Ultrasound Obstet Gynecol. 2022 Sep;60(3):381-389. doi: 10.1002/uog.24889. Ultrasound Obstet Gynecol. 2022. PMID: 35247287 Free PMC article.
-
[Placenta membranacea. Review of the literature, a case report].J Gynecol Obstet Biol Reprod (Paris). 1995;24(2):189-93. J Gynecol Obstet Biol Reprod (Paris). 1995. PMID: 7782592 Review. French.
-
Placenta accreta spectrum: accreta, increta, and percreta.Obstet Gynecol Clin North Am. 2015 Jun;42(2):381-402. doi: 10.1016/j.ogc.2015.01.014. Obstet Gynecol Clin North Am. 2015. PMID: 26002174 Review.
Cited by
-
Assessment of serum survivin in women with placenta previa and accreta spectrum: a cross-sectional study.Sci Rep. 2025 Feb 8;15(1):4735. doi: 10.1038/s41598-025-89384-4. Sci Rep. 2025. PMID: 39922950 Free PMC article.
References
-
- Rathbun K.M., Hildebrand J.P. StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2023. Placenta Abnormalities. - PubMed
-
- Luca F.-A., Ciobanu C.-I., Andrei A.G., Horodnic A.V. Raising Awareness on Health Impact of the Chemicals Used in Consumer Products: Empirical Evidence from East-Central Europe. Sustainability. 2018;10:209. doi: 10.3390/su10010209. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous